SDF-1-Edited Human Amniotic Mesenchymal Stem Cells Stimulate Angiogenesis in Treating Hindlimb Ischaemia

The authors generated long-term stromal cell-derived factor-1 secreting human amniotic mesenchymal stem cells (AMM/S) via TALEN-mediated editing and investigated to determine whether gene-edited AMM/S are novel angio-vasculogenic cell population in experimental ischaemia.